Ordering
Available Variants5 mg
CHA.53218-5mg
Price
€57.05
Available – Dispatch in 14 days
25 mg
CHA.53218-25mg
Price
€270.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.53218-5mg | €57.05 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.53218-25mg | €270.40 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C22H20N2O3 |
|---|---|
| CAS Number | 947914-18-3 |
| Molecular Weight | 360.41 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| MDL number | MFCD09204310 |
| Assay | ≥98% (HPLC) |
| Form | powder |
Safety Information Handling visibility
| Storage Class | 13 - Non Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
ML365, also known as CAS 947914-18-3, is a synthetic compound that has garnered significant attention in the scientific community due to its potential therapeutic applications. As a selective inhibitor of the enzyme soluble epoxide hydrolase, ML365 has been shown to exhibit anti-inflammatory properties, making it a promising candidate for the treatment of various inflammatory disorders. Research has demonstrated that ML365 can effectively reduce inflammation and oxidative stress in vitro and in vivo, suggesting its potential utility in the management of conditions such as cardiovascular disease and cancer. Further studies are necessary to fully elucidate the mechanisms of action and potential side effects of ML365, but its initial findings are encouraging and warrant continued investigation into its therapeutic potential. Additional research is needed to explore its clinical applications and potential benefits.
